India Glycols shifts Akshay Bansal to subsidiary EBL as Executive Director

Management Changes View source PDF Explain this filing

INDIAGLYCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.4%Reaction day

₹1144.50

prior close

₹1158.00

announcement price

After-mkt

timing

Nifty Microcap 250market+1.3%-1.7% vs market

Breweries & Distilleries peers, median of 25sector+1.0%-1.4% vs sector

On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 1.4 pts less than its Breweries & Distilleries peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.8

10m

-0.6

15m

-0.5

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.4+1.3-1.7+1.0-1.4

Next day

+1.8+1.8+0.0+1.1+0.7

+0.6+3.1-2.5+1.1-0.5

+0.4+3.5-3.0+1.0-0.6

-0.2+3.5-3.7+0.8-1.0

-5.4+3.4-8.8+0.5-5.9

-8.7+3.6-12.3+0.0-8.7

15d

+4.3+4.9-0.5-1.5+5.8

-78.3+4.4-82.7-1.8-76.5

-73.5+2.9-76.4-9.6-63.9

—————

UpDownMarket · Nifty Microcap 250Sector · Breweries & Distilleries peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

India Glycols has transferred Shri Akshay Bansal, Head of Sales & Marketing of its Ennature Biopharma Division, to wholly owned subsidiary Ennature Bio Pharma (EBL) effective 30 July 2026, ceasing to be Senior Managerial Personnel of the parent. EBL has appointed him as Additional Director (Executive Director) and KMP for a 5-year term ending 30 July 2031. The reshuffle is connected to the ongoing Scheme of Arrangement between India Glycols, EBL, and IGL Spirits Limited, which was earlier flagged by NSE and BSE observation letters in November 2025.

Likely market impact

Internal group restructuring tied to EBL subsidiary and the ongoing demerger-like scheme. No direct material financial impact on India Glycols shareholders.